TETON-PPF - A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
June 4, 2024
End Date
December 19, 2028
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
June 4, 2024
End Date
December 19, 2028